Molecular Templates, Inc.
MTEM
MTEM was delisted on the 24th of December, 2024.
52 hedge funds and large institutions have $29.8M invested in Molecular Templates, Inc. in 2018 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 16 increasing their positions, 4 reducing their positions, and 12 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 4
50% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 12
13% more funds holding
Funds holding: 46 → 52 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
28% less capital invested
Capital invested by funds: $41.6M → $29.8M (-$11.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$3.28M |
| 2 |
NC
Nexthera Capital
New York
|
+$1.3M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$904K |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$689K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$567K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
-$1.98M |
| 2 |
Millennium Management
New York
|
-$1.87M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$371K |
| 4 |
Goldman Sachs
New York
|
-$355K |
| 5 |
JP Morgan Chase
New York
|
-$315K |
MTEM Hedge Fund Activity: Q2 2018 in Review
52 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Molecular Templates, Inc. (MTEM) for Q2 2018, worth a combined $29.8M — down 28% from $41.6M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new MTEM positions and 12 closed out — a net gain of 6 holders — while 16 added to existing stakes and 4 trimmed.
The largest buyer was BlackRock, adding an estimated $3.28M. The largest seller was International Biotechnology Trust, exiting entirely with an estimated $1.98M sold.
- 52 institutional investors held Molecular Templates, Inc. (MTEM) as of Q2 2018, up from 46 in Q1 2018.
- Funds reported $29.8M of Molecular Templates, Inc. stock for Q2 2018, down 28% quarter-over-quarter.
- 18 funds opened new Molecular Templates, Inc. positions in Q2 2018 and 12 closed out, a net change of +6 holders.
- The largest Molecular Templates, Inc. buyer in Q2 2018 was BlackRock, an estimated $3.28M added.
- The largest Molecular Templates, Inc. seller in Q2 2018 was International Biotechnology Trust, an estimated $1.98M sold.
Based on aggregated 13F filings for Q2 2018.